Australia's most trusted
source of pharma news
Wednesday, 10 December 2025
Posted 8 December 2025 AM
Disruption across Australian pharma will heighten during 2026 with the difference between growth and decline "to be decided at the leadership table", according to an industry expert.
Director of Lighthouse Leadership Strategy and Training, Eric Miller, said ANZ remained one of the toughest markets globally and local leaders - many already stretched to breaking point - should expect even more challenges.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.